Article
Tissue transglutaminase contributes to the all-trans-retinoic acid-induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia.
Blood - 11 Nov 2010
Csomós Krisztián, Német István, Fésüs László, Balajthy Zoltán
Abstract excerpt
Treatment of acute promyelocytic leukemia (APL) with all-trans-retinoic acid (ATRA) results in terminal differentiation of leukemic cells toward neutrophil granulocytes. Administration of ATRA leads to massive changes in gene expression, including down-regulation of cell proliferation-related genes and induction of genes involved in immune function. One of the most induced genes in APL NB4 cells is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
